When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Got $2,000? 2 Top Growth Stocks to Buy and Hold for Years

   www.aol.com/finance/got-2-000-2-top-134500278.html

   DexCom also makes money from hardware, such as reusable transmitter devices that read sensor data for patients. The average cost of a sensor device with insurance is $30, but can range upwards of ...

3. Dexcom - Wikipedia

   en.wikipedia.org/wiki/Dexcom

   Dexcom was founded in 1999 by Scott Glenn, John Burd, Lauren Otsuki, Ellen Preston and Bret Megargel. [3] [4] In 2006, Dexcom received U.S. Food and Drug Administration (FDA) approval and launched the Dexcom STS Continuous Glucose Monitoring System, which is a three-day sensor that provides up to 288 glucose measurements for every 24 hours ...

4. Continuous glucose monitor - Wikipedia

   en.wikipedia.org/wiki/Continuous_glucose_monitor

   In 2012, Dexcom released a new device that allowed for the sensor to be worn for seven days and had a transmission distance of 20 feet. Dexcom later introduced an app allowing data from the sensor to be transmitted to an iPhone .

5. Automated insulin delivery system - Wikipedia

   en.wikipedia.org/wiki/Automated_insulin_delivery...

   ACE insulin pumps allow users to integrate continuous glucose monitors, automated insulin dosing (AID) systems, and other diabetes management devices with the pump to create a personalized diabetes therapy system. Many users of the t:slim X2 integrate the pump with the Dexcom G6, a continuous glucose monitor approved by the FDA in 2018.

6. Is DexCom a Millionaire Maker? - AOL

   www.aol.com/dexcom-millionaire-maker-120700315.html

   Right now, DexCom's stock is valued at a price-to-earnings (P/E) multiple of 42. Assuming that valuation holds up over time, it'd have a market cap of roughly $469 billion in 2034, or 1,605% ...

7. Dementia risk may be lowered by one important medical device

   www.aol.com/dementia-risk-may-lowered-one...

   Dexcom’s Stelo Glucose Biosensor System was the first over-the-counter CGM approved by the U.S. Food and Drug Administration (FDA) in March 2024, but it is only intended for people 18 years and ...